Total planned funding: $650,238,558
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Kenya | $134,250,000 |
| Nigeria | $111,043,364 |
| Ethiopia | $66,264,786 |
| Uganda | $60,651,312 |
| South Africa | $59,598,299 |
| Zambia | $39,612,000 |
| Tanzania | $31,392,693 |
| Côte d'Ivoire | $31,264,486 |
| Mozambique | $25,686,963 |
| Botswana | $18,969,409 |
| Rwanda | $15,220,553 |
| Vietnam | $14,812,000 |
| Haiti | $11,822,679 |
| Caribbean Region | $9,364,409 |
| Namibia | $8,404,930 |
| Zimbabwe | $7,230,000 |
| Guyana | $3,327,097 |
| Malawi | $650,000 |
| Eswatini | $320,000 |
| Lesotho | $176,578 |
| China | $100,000 |
| South Sudan | $77,000 |
Organizational Types
| Unknown | $269,366,794 |
| Private Contractor | $204,131,784 |
| NGO | $62,044,823 |
| University | $45,556,431 |
| FBO | $35,522,133 |
| Host Country Government Agency | $23,611,898 |
| Implementing Agency | $6,305,000 |
| Own Agency | $2,007,936 |
| Parastatal | $1,164,000 |
| Other USG Agency | $527,759 |
Program Areas
| Treatment | $650,238,558 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $650,238,558 |